Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
They may well be but a product also needs to be visible. Setting aside any personal views, the question needs to be asked why FF is not on the shelves with the myriad of other products? I don't see any valid excuse and it's obvious that a retail giant like H&B see no profit or sufficient consumer interest in the product.
I thought I would pop into H&B to see if FF was still stocked. This is a major branch in a big city. No sign among all the other cardiac stuff and the assistant said they hadn't stocked it for ages. No demand.
All going well isn't it?
Too expensive and under-advertised but the BOD are doing a fine job!
Lot's of irony today!
Not sure I agree with your 20% figure there everhopeful were did you get the info?
According to this info only 10% of the world population are classed as poor.
17% of the global population could be considered middle income
15% lived at an upper-middle-income
7% were high income leaving
51% low income.
https://www.pewresearch.org/fact-tank/2021/07/21/are-you-in-the-global-middle-class-find-out-with-our-income-calculator/
The US is maybe not a good comparison to all countries but 77 percent of U.S. adults take dietary supplements.
https://www.crnusa.org/newsroom/dietary-supplement-use-reaches-all-time-high
If Fruitflow is a successful product -does that mean Pxs is successful hooray!
Only about 20% of the world can afford FF and how many of them actually need it ? Anything decent and helpful gets by passed by big pharma , even suppressed in some cases EG GCMAF , David Noakes still in prison.
https://www.ukcolumn.org/article/gcmaf-and-persecution-david-noakes-lyn-thyer-immuno-biotech
At the very least, DSM will be able to supply there existing customers. What else comes out of the DSM negotiations we will just have to wait and see.
gix
good summary. BH Territories cover ~ 19% of the world population. Looking forward to seeing what IF has been doing to cover the remaining 81%. Hopefully companies here would be interested in a similar deal - personally think DSM should be in the mix somewhere but without any exclusivity..
W$
Also good to be mentioned in Pharma related journals.
May even help towards the long term plans????
"(2) During the period of the drug research and development agreement, Provexis and the company will cooperate in drug research and development projects in accordance with the terms of this agreement, and the company has the exclusive right to develop drugs in the area under the agreement."
http://data.eastmoney.com/notices/detail/300146/AN202111051527225504.html
Provexis and By-Health will seek to collaborate on research and development projects which may result in the development and approval of Fruitflow as a drug, for potential sale and distribution in the Territories.
https://otp.investis.com/clients/uk/provexis_plc/rns/regulatory-story.aspx?cid=1569&newsid=1523432
P.S. Nice rise in B-H share price today. Showing 9.34%
Good to be regarded as a successful product.
Another Mention in the pharma world
https://www.sciencedirect.com/science/article/abs/pii/S1043661821005855
https://www.google.co.uk/search?q=fruitflow%22The+current+use+and+evolving+landscape+of+nutraceuticals%22
2
4 Nov 2021 — The Current Use and Evolving Landscape of Nutraceuticals ... One such example of a successful product is Fruitflow® manufactured by Provexis ...
to be published in a pharma journal next month
https://www.sciencedirect.com/journal/pharmacological-research
About the journal
Formerly known as Pharmacological Research Communications;
Pharmacological Research publishes cutting-edge articles in biomedical sciences to cover a broad range of topics that move the pharmacological field forward. We provide a venue through which specialists across disciplines can rapidly exchange information in health sciences that pertains to modern …
https://dysw-cnki-net.translate.goog/kcms/detail/detail.aspx?filename=1021699508.nh&dbcode=CMFD&dbname=CMFDTEMP&v&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en
Find the ‘more’ to extend to full text.
Barbershop,
RE: but it wouldn't rule out us buying from DSM and them handling logistics to ship to China
Although a possibility I don't think that is the plan.
"The Agreement for Fruitflow announced today between the Company and By-Health falls under (ii) above, with the Company set to sell Fruitflow as an ingredient directly to By-Health from 1 January 2023; 100% of the Company's sales of Fruitflow to By-Health will accrue directly to the Company, and the Company will retain all of the resulting profits."
The company (PXS) is already in negotiations with the third party manufacturers.
"The Company and the third party manufacturers are actively engaged in some ongoing production capacity planning, looking at the steps required to scale-up the production of Fruitflow to meet the anticipated increase in demand."
Its a win win situation for Provexis and probably for By-Health as well as we could supply them with a cheaper product price and still come out with a higher profit.
Just in my opinion though.
Alf, how does my post suggesting that we could buy FF from DSM say that we would manufacture it ourselves?
DSM manufacture is what I'd said at the time. That might not add up as DSM don't manufacture as Gixer pointed out, but it wouldn't rule out us buying from DSM and them handling logistics to ship to China.
At no point did I suggest we manufacture ourselves....not sure why you want to drag that point out when what you claim is clearly untrue.
Its a good guess and we can only assume that it was for Team DSM and we received £9.2k for the Fruitflow+ nitrates development products in the year so it must have been a few packs :)
Again, only assuming but Fruitflow + Nitrates would be outside the Alliance Agreement.
That would make sense..... The Jan 21 interims do not indicate the nitrates were for the cycling team though. Doesn't really matter, all good progress..
From Jan 21 interims
Further interest in the role of Fruitflow in exercise has been generated by pro cycling Team DSM (formerly Team Sunweb)'s use of Fruitflow in the Tour de France. The benefits that Fruitflow can provide for athletes in terms of improved recovery are set out in more detail on the website at www.fruitflowplus.com/sportrecovery.
The Company continues to work on a potential Fruitflow+ nitrates product which would be supported by the Company's strong patent position in this area, with the involvement now of third party manufacturers and with some interest already generated from brand owners. The product will have anti-inflammatory and circulation benefits for athletes seeking to recover after exercise, properties which would also be potentially beneficial to a wide range of other consumers to include people who are less active and people who suffering from the symptoms of basic ageing.
Could it be what the cycling lads were taking?
I found this statement in the results intriguing
"In collaboration with DSM a trial batch of Fruitflow+ nitrates development products was manufactured during the year and sold to DSM."
Who did the selling ? Did DSM sell to itself ? Who supplied the nitrates ? SiS ?
W?
Yep, although I doubt anyone here has been invested from the formation of Provexis.
Your Sunday 12.03 post does say exactly that, and even suggests a mark up, I think that's why myself and gixer sought to clarify. All makes zero difference to the outcome, that's be down to the completion of studies and what effect they have on the opinions of health professionals. If there can be a proven link to aiding recovery from Covid symptoms, then Wellsite's comment that Fruitflow may be too big for Provexis to handle may well be highly viable IMHO
Well to be fair Alf, I'd never said we should be responsible for the manufacturing side, and that's what you seemed to be suggesting I had said.
Fair enough if we see things in a different way, but at least try to deal with people's opinions rather than things they haven't said.
Not sure why BB is taking umbridge though, just a few people bored senseless, having a chat after 15+ years of waiting...
..and all I said was it seemed an illogical position.
Polish that badge BB
:-)
Strange the links didn't work so try this.
https://bit.ly/3EsCCmZ
https://bit.ly/3xZPYV3
Evaluation of the equivalence of different intakes of Fruitflow in affecting platelet aggregation and thrombin generation capacity in a randomized, double-blinded pilot study in male subjects.
https://bm****r.biomedcentral.com/articles/10.1186/s40795-021-00485-5
Peer Review reports
https://bm****r.biomedcentral.com/articles/10.1186/s40795-021-00485-5/peer-review
BB,
"negative" no
"paranoid" no
But if Barbershop, or anyone else, feels like I have jumped down his/her throat because I simply disagreed with there statement then I apologise. It was not my intention to come across that way.
As we have already agreed to disagree I am unsure why you feel the need to bring it up again but my opinion, rightly or wrongly remains the same.
As Provexis is responsible for the manufacture, supply and sale of Fruitflow to By-Health I don't see how they can be classed as the middleman.
Does it matter either way? No.
Seems to me that some people are jumping down a poster's throat because they perceived the term "middleman" as negative and took umbrage at that.
If you own the IP, and act as a middleman, that's actually acknowledging your limitations and, almost certainly, maximising your returns. But if you're a bit paranoid about stuff posted, you might not see it like that.
See also https://dictionary.cambridge.org/dictionary/english/middleman
BB